Occurrence of an Adjudicated Secondary Stroke During the 30-month Treatment Period Because the study was terminated early, time frame is from beginning of treatment until end of treatment (up to 30 Months) [clinicaltrials_resource:072df34dc836076844a36a97ad2b90b1]
Secondary stroke is the first component of the composite primary endpoint and considers the number of participants with recurrent secondary stroke events during 30 months of treatment. Stroke was defined as any clinical event with brain injury due to vascular disease. All neurological events underwent formal stroke adjudication.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Occurrence of an Adjudicated Secondary Stroke During the 30-month Treatment Period Because the study was terminated early, time frame is from beginning of treatment until end of treatment (up to 30 Months) [clinicaltrials_resource:072df34dc836076844a36a97ad2b90b1]
Secondary stroke is the first component of the composite primary endpoint and considers the number of participants with recurrent secondary stroke events during 30 months of treatment. Stroke was defined as any clinical event with brain injury due to vascular disease. All neurological events underwent formal stroke adjudication.
Bio2RDF identifier
072df34dc836076844a36a97ad2b90b1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:072df34dc836076844a36a97ad2b90b1
measure [clinicaltrials_vocabulary:measure]
Occurrence of an Adjudicated Secondary Stroke During the 30-month Treatment Period
time frame [clinicaltrials_vocabulary:time-frame]
Because the study was terminat ...... of treatment (up to 30 Months)
description
Secondary stroke is the first ...... nt formal stroke adjudication.
identifier
clinicaltrials_resource:072df34dc836076844a36a97ad2b90b1
title
Occurrence of an Adjudicated S ...... of treatment (up to 30 Months)
@en
type
label
Occurrence of an Adjudicated S ...... df34dc836076844a36a97ad2b90b1]
@en